LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC.

Alexander, Marliese; Wei, Joe; Parakh, Sagun; John, Thomas; Kao, Steven; Nagrial, Adnan; Bowyer, Samantha; Warburton, Lydia; Moore, Melissa; Hughes, Brett G M; Clay, Timothy D; Pavlakis, Nick; Solomon, Benjamin J; Itchins, Malinda

Alexander, Marliese; Wei, Joe; Parakh, Sagun; John, Thomas; Kao, Steven; Nagrial, Adnan; Bowyer, Samantha; Warburton, Lydia; Moore, Melissa; Hughes, Brett G M; Clay, Timothy D; Pavlakis, Nick; Solomon, Benjamin J; Itchins, Malinda.

Afiliação

Alexander M; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Wei J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Parakh S; Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.
John T; Northern Clinical School, The University of Sydney, St. Leonards, New South Wales, Australia.
Kao S; Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia.
Nagrial A; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.
Bowyer S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Warburton L; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Moore M; Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Hughes BGM; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Clay TD; Department of Medical Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
Pavlakis N; Blacktown Hospital, Blacktown, New South Wales, Australia.
Solomon BJ; Westmead Clinical School, The University of Sydney, Westmead, New South Wales, Australia.
Itchins M; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.